Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion type Assertion NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_head.
- NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion wasGeneratedBy ECO_0000203 NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_provenance.
- NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion wasDerivedFrom befree-20140225 NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_provenance.
- NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion SIO_000772 17943075 NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_provenance.
- NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion evidence source_evidence_literature NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_provenance.
- NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_assertion description "[Our data thus indicate that, by the downregulation of the NF-kappaBeta target genes that are critical in thrombosis and inflammation, specific inhibitors of p50, such as Andro, may be therapeutically valuable for preventing and treating thrombotic arterial diseases, including neointimal hyperplasia in arterial restenosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266208.RAFKzZd0Ruqht9niSvnCG6V5IvuaD0Qy8PbkBV-EHuh4Q130_provenance.